ALNYLAM PHARMACEUTICALS, INC. 4
4 · ALNYLAM PHARMACEUTICALS, INC. · Filed Jun 10, 2015
Insider Transaction Report
Form 4
Gros David-Alexandre C
SVP, Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2015-06-08+140,000→ 140,000 totalExercise: $129.97Exp: 2025-06-08→ Common Stock (140,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.